Valuation: Xiamen Kingdomway Group Company

Capitalization	11.08B 1.62B 1.38B 1.28B 1.2B 2.24B 151B 2.29B 15B 5.87B 72.45B 6.09B 5.96B 258B	P/E ratio 2025 *	25.2x	P/E ratio 2026 *	17.1x
Enterprise value	11.08B 1.62B 1.38B 1.28B 1.2B 2.24B 151B 2.29B 15B 5.87B 72.45B 6.09B 5.96B 258B	EV / Sales 2025 *	3.14x	EV / Sales 2026 *	2.42x
Free-Float	40.76%	Yield 2025 *	-	Yield 2026 *	-

* Estimated data More valuation ratios

Chart: Xiamen Kingdomway Group Company

Timeframe

Style

Dynamic Chart

Latest news: Xiamen Kingdomway Group Company

Jan. 07	Xiamen Kingdomway Group Company Receives New Dietary Ingredient Letter from the Food and Drug Administration	CI
25-10-24	Xiamen Kingdomway Group Company Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-09-11	Xiamen Kingdomway Group's Worm Infection Drug Approved in China	MT
25-08-27	Xiamen Kingdomway Group Company Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-17	Xiamen Kingdomway to issue convertible bonds raising up to 1.29 bln yuan	RE
25-08-05	Xiamen Kingdomway Unit to Invest 3 Million Yuan Neutracetical JV	MT
25-05-16	Xiamen Kingdomway Group Company Appoints Xu Xiaote as Non-Independent Director	CI
25-05-06	Xiamen Kingdomway Group Company Approves Cash Dividend on Share A for the Year 2024, Payable on June 20, 2025	CI
25-04-28	Xiamen Kingdomway Group Company Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-10	Xiamen Kingdomway Group Company Proposes Final Cash Dividend for the Year 2024	CI
25-04-10	Xiamen Kingdomway Says U.S. Tariff Increase Will Not Impact Production, Operation	RE
25-04-09	Xiamen Kingdomway Group Company Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-27	Xiamen Kingdomway Group Company Reports Earnings Results for the Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Xiamen Kingdomway Group Company

Manager	Title	Age	Since
Bin Jiang CEO	Chief Executive Officer	59	2010-04-17
Hang Hong DFI	Director of Finance/CFO	44	2016-04-11
Jia Liang Chen PRN	Corporate Officer/Principal	62	2013-04-09

Director	Title	Age	Since
Shui Hua Wang BRD	Director/Board Member	60	2022-05-16
Bin Jiang CHM	Chairman	59	1996-12-31
Jia Liang Chen BRD	Director/Board Member	62	2010-04-17

More insiders

Special Foods & Wellbeing Products

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
XIAMEN KINGDOMWAY GROUP COMPANY	+1.79%	+4.73%	+25.07%	-23.02%	1.62B
ZHEJIANG NHU COMPANY LTD.	-0.84%	+1.81%	+76.68%	+103.28%	16.39B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-1.81%	+0.28%	-21.46%	+218.05%	6.65B
BYHEALTH CO., LTD	+0.37%	+1.77%	-1.88%	-51.97%	2.69B
BELLRING BRANDS, INC.	-2.53%	-9.69%	-80.14%	-55.18%	1.76B
HERBALIFE LTD.	+0.40%	+9.65%	+127.65%	-1.04%	1.57B
TSI GROUP CO., LTD.	+2.20%	+6.62%	-	-	1.5B
JAMIESON WELLNESS INC.	-1.11%	-2.02%	+10.96%	+0.68%	1.01B
THE SIMPLY GOOD FOODS COMPANY	-11.53%	-26.27%	-72.53%	-71.94%	945M
SIRIO PHARMA CO., LTD.	+1.03%	+3.67%	+9.31%	-0.65%	924M
Average	-1.20%	-0.99%	+8.18%	+13.13%	3.51B
Weighted average by Cap.	-0.96%	+0.80%	+34.59%	+83.39%

See all sector performances

Xiamen Kingdomway Group Company is a China-based company principally engaged in the production and distribution of nutrition enhancers and health care products. The Company mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The Company distributes its products within domestic market and to overseas markets.

Employees

2,123

Sector

Food Processing

Calendar

Apr. 21 - Earnings release - Annual 2025

More about the company

Quotes

Date	Price	Change	Volume
26-04-10	18.16 ¥	+1.79%	6,717,400
26-04-09	17.84 ¥	-1.38%	4,777,500
26-04-08	18.09 ¥	+1.74%	5,897,476
26-04-07	17.78 ¥	+2.54%	4,174,123
26-04-03	17.34 ¥	-2.03%	5,021,700

End-of-day quote Shenzhen S.E.

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.16CNY

Average target price

25.70CNY

Spread / Average Target

+41.52%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Shenzhen S.E. Other stock markets 2026-04-10			5-day change	1st Jan Change
18.16 ^CNY	+1.79%		+4.73%	-7.86%

1 day	+1.79%
1 week	+4.73%
Current month	+3.53%
1 month	-2.99%
3 months	-9.56%
6 months	-11.46%
Current year	-7.86%

1 week	17.28	18.48
1 month	16.19	20.27
Current year	16.19	20.81
1 year	14.53	22.44
3 years	10.71	24.7
5 years	10.71	51.23
10 years	10.71	64.48

	2025 *	2026 *
Net sales	3.53B 517M 440M 407M 384M 714M 48.06B 729M 4.78B 1.87B 23.08B 1.94B 1.9B 82.23B	4.58B 671M 571M 529M 498M 927M 62.38B 946M 6.2B 2.43B 29.96B 2.52B 2.46B 107B
Net income	442M 64.74M 55.15M 51.04M 48.06M 89.51M 6.02B 91.35M 599M 234M 2.89B 243M 238M 10.3B	648M 94.88M 80.83M 74.8M 70.43M 131M 8.82B 134M 878M 343M 4.24B 356M 349M 15.1B
Net Debt	-	-

Xiamen Kingdomway Group Company Stock

Equities

002626

CNE1000018X4